Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Astellas Pays, And Pays Big, To Extend VelocImmune License With Regeneron

Jul 28 2010

• By The Pink Sheet Daily

Related Content

Sanofi Makes its Biggest External Play Yet With Long-Term Regeneron Deal

Dec 01 2009

FDA Aims To Clear Hurdles For Severe Bleeding Products With Workshop, Advisory Committee

Nov 29 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window